MFDS — authorised 4 June 1965
- Marketing authorisation holder: ADVANCE BIOFACTURES
- Status: likely_approved
🇰🇷 Xiaflex in South Korea
MFDS authorised Xiaflex on 4 June 1965
Marketing authorisation
Xiaflex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Xiaflex approved in South Korea?
Yes. MFDS authorised it on 4 June 1965.
Who is the marketing authorisation holder for Xiaflex in South Korea?
ADVANCE BIOFACTURES holds the South Korean marketing authorisation.